GMP

Health Canada GMP inspection at Neova Technologies Inc.

  • Posted on: 21 September 2018
  • By: admin
Health Canada Inspection at Neova Technologies Inc.

In August 2018 Neova Technologies Inc. (NTI), a Bioseutica Group company had an inspection by Health Canada and received a compliance rating indicating that the activities inspected met the requirements outlined in the Canadian Food & Drug Act and its associated regulations. NTI has received their Establishment License to manufacture, package, label and test non-sterile Active Pharmaceutical Ingredients (APIs) specifically Trypsin. Neova Technologies Inc. produce pancreatic enzymes such as trypsin, chymotrypsin, phospholipase A2 for food, diagnostics, healthcare and feed industries.

Tags: